Infertility Testing Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Infertility Testing Market to 2027 - Global Analysis and Forecasts By Type (Female Infertility Testing, Male Infertility Testing), Test Kits (Human Follicular Stimulating Hormone (FSH) Urine Test Kits, Human Chorionic Gonadotropin (HCG) Hormone Blood Test Kits, Luteinizing Hormone (LH) Urine Test Kits, and Others), Prescription Mode (Prescription-Based, Over The Counter (OTC) Based), Distribution Channel (Hospitals Pharmacies, Pharmacies & Drug Stores, and Online Pharmacies), End User (Hospitals & Clinics, Fertility Centers, Research Institutes, and other End Users) and Geography

Report Code: TIPHE100001421 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
MARKET INTRODUCTION
Fertility testing is done by both men and women for the evaluation of their fertility and various conditions associated with it. The assessment of infertility proceeds along simple and logical lines which includes test for eggs, test for sperm, and how they can get together. Additional tests are performed based on the completion of this three step process. Men and women both experience the fertility problems at equal rates, but women are considered to be more concerned regarding fertility testing.

MARKET DYNAMICS
Decline in fertility rates, increasing number of fertility clinics, rising number of gynecological disorders and technological advancements and innovative testing products are expected to drive the growth of the market in the coming years. Increasing awareness among the female population is expected to offer growth opportunities for the manufacturers operating in the market during the forecast period.

MARKET SCOPE
The "Global Infertility testing Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a focus on the global infertility testing market trend. The report aims to provide an overview of global Infertility testing market with detailed market segmentation by type, test kits, prescription mode, distribution channel, end user, and geography. The global infertility testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the Infertility testing market.

MARKET SEGMENTATION
The global infertility testing market is segmented on the basis of type, test kits, prescription mode, distribution channel, and end user. Based on type, the infertility testing market is categorized as, female infertility testing, male infertility testing. On the basis of test kits the Infertility testing market is categorized as, human follicular stimulating hormone (FSH) urine test kits, human chorionic gonadotropin (HCG) hormone blood test kits, luteinizing hormone (LH) urine test kits, and others. Based on prescription mode, the infertility testing market is segmented into prescription-based and over the counter (OTC) based. On the basis on distribution channel, the infertility testing market is segmented as, hospitals pharmacies, pharmacies & drug stores, and online pharmacies. On the basis on end user, the Infertility testing market is segmented as, hospitals & clinics, fertility centers, research institutes, and other end users.
 
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global infertility testing market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The infertility testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting infertility testing market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the infertility testing market in these regions.
 
MARKET PLAYERS
The reports cover key developments in the infertility testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from infertility testing market are anticipated to lucrative growth opportunities in the future with the rising demand for infertility testing in the global market. Below mentioned is the list of few companies engaged in the infertility testing market.

The report also includes the profiles of key infertility testing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Merck KGaA
  • Procter & Gamble
  • bioMerieux SA
  • Alere Inc.
  • Babystart Ltd.
  • bioZhena Corporation
  • Quidel Corporation
  • SPD Swiss Precision Diagnostics GmbH
  • SCSA Diagnostics, Inc.
  • Pride Angel
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
 

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1. Infertility Testing Market - By Type
1.3.2. Infertility Testing Market - By Test Kits
1.3.3. Infertility Testing Market - By Prescription Mode
1.3.4. Infertility Testing Market - By Distribution Channel
1.3.5. Infertility Testing Market - By End User
1.3.6. Infertility Testing Market - By Region
1.3.6.1. By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. INFERTILITY TESTING MARKET LANDSCAPE
4.1. MARKET OVERVIEW
4.2. PEST ANALYSIS
4.2.1. North America - PEST Analysis
4.2.2. Europe - PEST Analysis
4.2.3. Asia Pacific - PEST Analysis
4.2.4. Middle East & Africa - PEST Analysis
4.2.5. South and Central America - PEST Analysis

5. INFERTILITY TESTING MARKET- KEY INDUSTRY DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. INFERTILITY TESTING MARKET- GLOBAL ANALYSIS
6.1. INFERTILITY TESTING MARKET - GLOBAL MARKET OVERVIEW
6.2. INFERTILITY TESTING MARKET - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/ MARKET SHARE OF KEY PLAYERS

7. INFERTILITY TESTING MARKET REVENUE AND FORECASTS TO 2027 - BY TYPE
7.1. OVERVIEW
7.2. TYPE MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. FEMALE INFERTILITY TESTING MARKET
7.3.1. Overview
7.3.2. Female Infertility Testing Market Revenue Forecasts and Analysis (US$ Mn)
7.4. MALE INFERTILITY TESTING MARKET
7.4.1. Overview
7.4.2. Male Infertility Testing Market Revenue Forecasts and Analysis (US$ Mn)
7.4.3. )

8. INFERTILITY TESTING MARKET REVENUE AND FORECASTS TO 2027 - BY TEST KITS
8.1. OVERVIEW
8.2. TEST KITS MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
8.3. HUMAN FOLLICULAR STIMULATING HORMONE (FSH) URINE TEST KITS MARKET
8.3.1. Overview
8.3.2. Human Follicular Stimulating Hormone (FSH) Urine Test Kits Market Revenue Forecasts and Analysis (US$ Mn)
8.4. HUMAN CHORIONIC GONADOTROPIN (HCG) HORMONE BLOOD TEST KITS MARKET
8.4.1. Overview
8.4.2. Human Chorionic Gonadotropin (HCG) Hormone Blood Test Kits Market Revenue Forecasts and Analysis (US$ Mn)
8.5. LUTEINIZING HORMONE (LH) URINE TEST KITS MARKET
8.5.1. Overview
8.5.2. Luteinizing Hormone (LH) Urine Test Kits Market Revenue Forecasts and Analysis (US$ Mn)
8.6. OTHERS MARKET
8.6.1. Overview
8.6.2. Others Market Revenue Forecasts and Analysis (US$ Mn)

9. INFERTILITY TESTING MARKET REVENUE AND FORECASTS TO 2027 - BY PRESCRIPTION MODE
9.1. OVERVIEW
9.2. PRESCRIPTION MODE MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
9.3. PRESCRIPTION-BASED MARKET
9.3.1. Overview
9.3.2. Prescription-Based Market Revenue Forecasts and Analysis (US$ Mn)
9.4. OVER THE COUNTER (OTC) BASED MARKET
9.4.1. Overview
9.4.2. Over The Counter (OTC) Based Market Revenue Forecasts and Analysis (US$ Mn)

10. INFERTILITY TESTING MARKET REVENUE AND FORECASTS TO 2027 - BY DISTRIBUTION CHANNEL
10.1. OVERVIEW
10.2. DISTRIBUTION CHANNEL MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
10.3. HOSPITALS PHARMACIES MARKET
10.3.1. Overview
10.3.2. Hospitals Pharmacies Market Revenue Forecasts and Analysis (US$ Mn)
10.4. PHARMACIES & DRUG STORES MARKET
10.4.1. Overview
10.4.2. Pharmacies & Drug Stores Market Revenue Forecasts and Analysis (US$ Mn)
10.5. ONLINE PHARMACIES MARKET
10.5.1. Overview
10.5.2. Online Pharmacies Market Revenue Forecasts and Analysis (US$ Mn)

11. INFERTILITY TESTING MARKET REVENUE AND FORECASTS TO 2027 - BY END USER
11.1. OVERVIEW
11.2. END USER MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
11.3. HOSPITALS & CLINICS MARKET
11.3.1. Overview
11.3.2. Hospitals & Clinics Market Revenue Forecasts and Analysis (US$ Mn)
11.4. FERTILITY CENTERS MARKET
11.4.1. Overview
11.4.2. Fertility Centers Market Revenue Forecasts and Analysis (US$ Mn)
11.5. RESEARCH INSTITUTES MARKET
11.5.1. Overview
11.5.2. Research Institutes Market Revenue Forecasts and Analysis (US$ Mn)
11.6. OTHER END USERS MARKET
11.6.1. Overview
11.6.2. Other End Users Market Revenue Forecasts and Analysis (US$ Mn)

12. INFERTILITY TESTING MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
12.1. NORTH AMERICA INFERTILITY TESTING MARKET
12.1.1. North America Infertility Testing Market Forecasts and Analysis (US$ Mn)
12.1.2. North America Infertility Testing Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.1.3. North America Infertility Testing Market Revenue and Forecasts Analysis - By Test Kits (US$ Mn)
12.1.4. North America Infertility Testing Market Revenue and Forecasts Analysis - By Prescription Mode (US$ Mn)
12.1.5. North America Infertility Testing Market Revenue and Forecasts Analysis - By Distribution Channel (US$ Mn)
12.1.6. North America Infertility Testing Market Revenue and Forecasts Analysis - By End User (US$ Mn)
12.1.7. North America Infertility Testing Market Forecasts and Analysis - By Country
12.1.8. US Market Overview
12.1.8.1. US Infertility Testing Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.1.8.2. US Infertility Testing Market Revenue Forecasts and Analysis - By Test Kits (US$ Mn)
12.1.8.3. US Infertility Testing Market Revenue Forecasts and Analysis - By Prescription Mode (US$ Mn)
12.1.8.4. US Infertility Testing Market Revenue Forecasts and Analysis - By Distribution Channel (US$ Mn)
12.1.8.5. US Infertility Testing Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.1.9. Canada Market Overview
12.1.9.1. Canada Infertility Testing Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.1.9.2. Canada Infertility Testing Market Revenue Forecasts and Analysis - By Test Kits (US$ Mn)
12.1.9.3. Canada Infertility Testing Market Revenue Forecasts and Analysis - By Prescription Mode (US$ Mn)
12.1.9.4. Canada Infertility Testing Market Revenue Forecasts and Analysis - By Distribution Channel (US$ Mn)
12.1.9.5. Canada Infertility Testing Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.1.10. Mexico Market Overview
12.1.10.1. Mexico Infertility Testing Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.1.10.2. Mexico Infertility Testing Market Revenue Forecasts and Analysis - By Test Kits (US$ Mn)
12.1.10.3. Mexico Infertility Testing Market Revenue Forecasts and Analysis - By Prescription Mode (US$ Mn)
12.1.10.4. Mexico Infertility Testing Market Revenue Forecasts and Analysis - By Distribution Channel (US$ Mn)
12.1.10.5. Mexico Infertility Testing Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.2. EUROPE INFERTILITY TESTING MARKET
12.2.1. Europe Infertility Testing Market Forecasts and Analysis (US$ Mn)
12.2.2. Europe Infertility Testing Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.2.3. Europe Infertility Testing Market Revenue and Forecasts Analysis - By Test Kits (US$ Mn)
12.2.4. Europe Infertility Testing Market Revenue and Forecasts Analysis - By Prescription Mode (US$ Mn)
12.2.5. Europe Infertility Testing Market Revenue and Forecasts Analysis - By Distribution Channel (US$ Mn)
12.2.6. Europe Infertility Testing Market Revenue and Forecasts Analysis - By End User (US$ Mn)
12.2.7. Europe Infertility Testing Market Forecasts and Analysis - By Country
12.2.8. UK Market Overview
12.2.8.1. UK Infertility Testing Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.2.8.2. UK Infertility Testing Market Revenue Forecasts and Analysis - By Test Kits (US$ Mn)
12.2.8.3. UK Infertility Testing Market Revenue Forecasts and Analysis - By Prescription Mode (US$ Mn)
12.2.8.4. UK Infertility Testing Market Revenue Forecasts and Analysis - By Distribution Channel (US$ Mn)
12.2.8.5. UK Infertility Testing Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.2.9. Germany Market Overview
12.2.9.1. Germany Infertility Testing Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.2.9.2. Germany Infertility Testing Market Revenue Forecasts and Analysis - By Test Kits (US$ Mn)
12.2.9.3. Germany Infertility Testing Market Revenue Forecasts and Analysis - By Prescription Mode (US$ Mn)
12.2.9.4. Germany Infertility Testing Market Revenue Forecasts and Analysis - By Distribution Channel (US$ Mn)
12.2.9.5. Germany Infertility Testing Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.2.10. France Market Overview
12.2.10.1. France Infertility Testing Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.2.10.2. France Infertility Testing Market Revenue Forecasts and Analysis - By Test Kits (US$ Mn)
12.2.10.3. France Infertility Testing Market Revenue Forecasts and Analysis - By Prescription Mode (US$ Mn)
12.2.10.4. France Infertility Testing Market Revenue Forecasts and Analysis - By Distribution Channel (US$ Mn)
12.2.10.5. France Infertility Testing Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.2.11. Italy Market Overview
12.2.11.1. Italy Infertility Testing Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.2.11.2. Italy Infertility Testing Market Revenue Forecasts and Analysis - By Test Kits (US$ Mn)
12.2.11.3. Italy Infertility Testing Market Revenue Forecasts and Analysis - By Prescription Mode (US$ Mn)
12.2.11.4. Italy Infertility Testing Market Revenue Forecasts and Analysis - By Distribution Channel (US$ Mn)
12.2.11.5. Italy Infertility Testing Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.2.12. Spain Market Overview
12.2.12.1. Spain Infertility Testing Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.2.12.2. Spain Infertility Testing Market Revenue Forecasts and Analysis - By Test Kits (US$ Mn)
12.2.12.3. Spain Infertility Testing Market Revenue Forecasts and Analysis - By Prescription Mode (US$ Mn)
12.2.12.4. Spain Infertility Testing Market Revenue Forecasts and Analysis - By Distribution Channel (US$ Mn)
12.2.12.5. Spain Infertility Testing Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.3. ASIA PACIFIC INFERTILITY TESTING MARKET
12.3.1. Asia Pacific Infertility Testing Market Forecasts and Analysis (US$ Mn)
12.3.2. Asia Pacific Infertility Testing Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.3.3. Asia Pacific Infertility Testing Market Revenue and Forecasts Analysis - By Test Kits (US$ Mn)
12.3.4. Asia Pacific infertility testing Market Revenue and Forecasts Analysis - By Prescription Mode (US$ Mn)
12.3.5. Asia Pacific infertility testing Market Revenue and Forecasts Analysis - By Distribution Channel (US$ Mn)
12.3.6. Asia Pacific infertility testing Market Revenue and Forecasts Analysis - By End User (US$ Mn)
12.3.7. Asia Pacific Infertility Testing Market Forecasts and Analysis - By Country
12.3.8. China Market Overview
12.3.8.1. China Infertility Testing Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.3.8.2. China Infertility Testing Market Revenue Forecasts and Analysis - By Test Kits (US$ Mn)
12.3.8.3. China Infertility Testing Market Revenue Forecasts and Analysis - By Prescription Mode (US$ Mn)
12.3.8.4. China Infertility Testing Market Revenue Forecasts and Analysis - By Distribution Channel (US$ Mn)
12.3.8.5. China Infertility Testing Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.3.9. Japan Market Overview
12.3.9.1. Japan Infertility Testing Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.3.9.2. Japan Infertility Testing Market Revenue Forecasts and Analysis - By Test Kits (US$ Mn)
12.3.9.3. Japan Infertility Testing Market Revenue Forecasts and Analysis - By Prescription Mode (US$ Mn)
12.3.9.4. Japan Infertility Testing Market Revenue Forecasts and Analysis - By Distribution Channel (US$ Mn)
12.3.9.5. Japan Infertility Testing Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.3.10. India Market Overview
12.3.10.1. India Infertility Testing Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.3.10.2. India Infertility Testing Market Revenue Forecasts and Analysis - By Test Kits (US$ Mn)
12.3.10.3. India Infertility Testing Market Revenue Forecasts and Analysis - By Prescription Mode (US$ Mn)
12.3.10.4. India Infertility Testing Market Revenue Forecasts and Analysis - By Distribution Channel (US$ Mn)
12.3.10.5. India Infertility Testing Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.3.11. Australia Market Overview
12.3.11.1. Australia Infertility Testing Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.3.11.2. Australia Infertility Testing Market Revenue Forecasts and Analysis - By Test Kits (US$ Mn)
12.3.11.3. Australia Infertility Testing Market Revenue Forecasts and Analysis - By Prescription Mode (US$ Mn)
12.3.11.4. Australia Infertility Testing Market Revenue Forecasts and Analysis - By Distribution Channel (US$ Mn)
12.3.11.5. Australia Infertility Testing Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.3.12. South Korea Market Overview
12.3.12.1. South Korea Infertility Testing Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.3.12.2. South Korea Infertility Testing Market Revenue Forecasts and Analysis - By Test Kits (US$ Mn)
12.3.12.3. South Korea Infertility Testing Market Revenue Forecasts and Analysis - By Prescription Mode (US$ Mn)
12.3.12.4. South Korea Infertility Testing Market Revenue Forecasts and Analysis - By Distribution Channel (US$ Mn)
12.3.12.5. South Korea Infertility Testing Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.4. MIDDLE EAST & AFRICA (MEA) INFERTILITY TESTING MARKET
12.4.1. Middle East & Africa (MEA) Infertility Testing Market Forecasts and Analysis (US$ Mn)
12.4.2. Middle East & Africa (MEA) Infertility Testing Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.4.3. Middle East & Africa (MEA) Infertility Testing Market Revenue and Forecasts Analysis - By Test Kits (US$ Mn)
12.4.4. Middle East & Africa (MEA) Infertility Testing Market Revenue and Forecasts Analysis - By Prescription Mode (US$ Mn)
12.4.5. Middle East & Africa (MEA) Infertility Testing Market Revenue and Forecasts Analysis - By Distribution Channel (US$ Mn)
12.4.6. Middle East & Africa (MEA) Infertility Testing Market Revenue and Forecasts Analysis - By End User (US$ Mn)
12.4.7. Middle East & Africa (MEA) Infertility Testing Market Forecasts and Analysis - By Country
12.4.8. UAE Overview
12.4.8.1. UAE Infertility Testing Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.4.8.2. UAE Infertility Testing Market Revenue Forecasts and Analysis - By Test Kits (US$ Mn)
12.4.8.3. UAE Infertility Testing Market Revenue Forecasts and Analysis - By Prescription Mode (US$ Mn)
12.4.8.4. UAE Infertility Testing Market Revenue Forecasts and Analysis - By Distribution Channel (US$ Mn)
12.4.8.5. UAE Infertility Testing Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.4.9. Saudi Arabia Market Overview
12.4.9.1. Saudi Arabia Infertility Testing Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.4.9.2. Saudi Arabia Infertility Testing Market Revenue Forecasts and Analysis - By Test Kits (US$ Mn)
12.4.9.3. Saudi Arabia Infertility Testing Market Revenue Forecasts and Analysis - By Prescription Mode (US$ Mn)
12.4.9.4. Saudi Arabia Infertility Testing Market Revenue Forecasts and Analysis - By Distribution Channel (US$ Mn)
12.4.9.5. Saudi Arabia Infertility Testing Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.4.10. South Africa Market Overview
12.4.10.1. South Africa Infertility Testing Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.4.10.2. South Africa Infertility Testing Market Revenue Forecasts and Analysis - By Test Kits (US$ Mn)
12.4.10.3. South Africa Infertility Testing Market Revenue Forecasts and Analysis - By Prescription Mode (US$ Mn)
12.4.10.4. South Africa Infertility Testing Market Revenue Forecasts and Analysis - By Distribution Channel (US$ Mn)
12.4.10.5. South Africa Infertility Testing Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.5. SOUTH AND CENTRAL AMERICA INFERTILITY TESTING MARKET
12.5.1. South and Central America Infertility Testing Market Forecasts and Analysis (US$ Mn)
12.5.2. South and Central America Infertility Testing Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.5.3. South and Central America Infertility Testing Market Revenue and Forecasts Analysis - By Test Kits (US$ Mn)
12.5.4. South and Central America Infertility Testing Market Revenue and Forecasts Analysis - By Prescription Mode (US$ Mn)
12.5.5. South and Central America Infertility Testing Market Revenue and Forecasts Analysis - By Distribution Channel (US$ Mn)
12.5.6. South and Central America Infertility Testing Market Revenue and Forecasts Analysis - By End User (US$ Mn)
12.5.7. South and Central America Infertility Testing Market Forecasts and Analysis - By Country
12.5.8. Brazil Market Overview
12.5.8.1. Brazil Infertility Testing Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.5.8.2. Brazil Infertility Testing Market Revenue Forecasts and Analysis - By Test Kits (US$ Mn)
12.5.8.3. Brazil Infertility Testing Market Revenue Forecasts and Analysis - By Prescription Mode (US$ Mn)
12.5.8.4. Brazil Infertility Testing Market Revenue Forecasts and Analysis - By Distribution Channel (US$ Mn)
12.5.8.5. Brazil Infertility Testing Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.5.9. Argentina Market Overview
12.5.9.1. Argentina Infertility Testing Market Revenue Forecasts and Analysis - By Type (US$ Mn)
12.5.9.2. Argentina Infertility Testing Market Revenue Forecasts and Analysis - By Test Kits (US$ Mn)
12.5.9.3. Argentina Infertility Testing Market Revenue Forecasts and Analysis - By Prescription Mode (US$ Mn)
12.5.9.4. Argentina Infertility Testing Market Revenue Forecasts and Analysis - By Distribution Channel (US$ Mn)
12.5.9.5. Argentina Infertility Testing Market Revenue Forecasts and Analysis - By End User (US$ Mn)

13. INDUSTRY LANDSCAPE
13.1. ORGANIC GROWTH STRATEGIES
13.1.1. New Product Launches
13.1.2. Marketing & Promotional Activities
13.2. INORGANIC GROWTH STRATEGIES
13.2.1. Partnerships, Collaborations, and Joint Ventures
13.2.2. Mergers & Acquisitions

14. INFERTILITY TESTING MARKET, KEY COMPANY PROFILES
14.1. MERCK KGAA
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Financial Overview
14.1.4. Product Portfolio
14.1.5. Product Pipeline
14.1.6. SWOT Analysis
14.1.7. Key Developments
14.2. PROCTER & GAMBLE
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Financial Overview
14.2.4. Product Portfolio
14.2.5. Product Pipeline
14.2.6. SWOT Analysis
14.2.7. Key Developments
14.3. BIOMÉRIEUX SA
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Financial Overview
14.3.4. Product Portfolio
14.3.5. Product Pipeline
14.3.6. SWOT Analysis
14.3.7. Key Developments
14.4. ALERE INC.
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Financial Overview
14.4.4. Product Portfolio
14.4.5. Product Pipeline
14.4.6. SWOT Analysis
14.4.7. Key Developments
14.5. BABYSTART LTD.
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Financial Overview
14.5.4. Product Portfolio
14.5.5. Product Pipeline
14.5.6. SWOT Analysis
14.5.7. Key Developments
14.6. BIOZHENA CORPORATION
14.6.1. Business Description
14.6.2. Financial Overview
14.6.3. Product Portfolio
14.6.4. Product Pipeline
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. QUIDEL CORPORATION
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Financial Overview
14.7.4. Product Portfolio
14.7.5. Product Pipeline
14.7.6. SWOT Analysis
14.7.7. Key Developments
14.8. SPD SWISS PRECISION DIAGNOSTICS GMBH
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Financial Overview
14.8.4. Product Portfolio
14.8.5. Product Pipeline
14.8.6. SWOT Analysis
14.8.7. Key Developments
14.9. SCSA DIAGNOSTICS, INC.
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Financial Overview
14.9.4. Product Portfolio
14.9.5. Product Pipeline
14.9.6. SWOT Analysis
14.9.7. Key Developments
14.10.  PRIDE ANGEL
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Financial Overview
14.10.4. Product Portfolio
14.10.5. Product Pipeline
14.10.6. SWOT Analysis
14.10.7. Key Developments

15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS

 

The List of Companies

1. Merck KGaA
2. Procter & Gamble
3. bioMerieux SA
4. Alere Inc.
5. Babystart Ltd.
6. bioZhena Corporation
7. Quidel Corporation
8. SPD Swiss Precision Diagnostics GmbH
9. SCSA Diagnostics, Inc.
10. Pride Angel